Republican lawmakers intend to make big cuts to Medicaid and, if those cuts are realized, there is no way Centene and Molina's business will remain unscathed, said Dr. Mario Molina, who served as CEO ...
Joseph Zubretsky, CEO of Molina Healthcare, told investors he expects any cuts to Medicaid in 2025 to be "marginal." Mr. Zubretsky does not expect these proposals to be politically palatable. "Neither ...
and welcome to Molina Healthcare's fourth quarter and full year 2024 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky, and our CFO, Mark Keim. A press release ...
Joseph Zubretsky; President, Chief Executive Officer, Director; Molina Healthcare Inc Mark Keim; Chief Financial Officer, Senior Executive Vice President; Molina Healthcare Inc Good day ...
Joseph Zubretsky; President, Chief Executive Officer, Director; Molina Healthcare Inc Mark Keim; Chief Financial Officer, Senior Executive Vice President; Molina Healthcare Inc Good day, and welcome ...
Good day and welcome to Molina Healthcare Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being ...
Molina’s Medicaid ... behavioral healthcare and high-cost therapies such as glucagon-like peptide-1 agonists drove the increase, Zubretsky said during a call with investor analysts.
CEO Zubretsky explained the 2025 projection ... raising concerns about their effectiveness as a financial buffer in 2025. Molina Healthcare's Q4 2024 results reflected ongoing medical cost ...
Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted ...
Detailed price information for Molina Healthcare Inc (MOH-N) from The Globe and Mail including charting and trades.